(Q33925727)

30 July 2017

1 reference

title

Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome (English)

1 reference

30 July 2017

0 references

2

Crofford LJ

1 reference

30 July 2017

Neeck G

1

1 reference

30 July 2017

1 November 2000

1 reference

Rheumatic Diseases Clinics of North America

30 July 2017

1 reference

30 July 2017

26

1 reference

30 July 2017

4

1 reference

30 July 2017

989-1002

1 reference

Genetics and pathophysiology of affective disorders: relationship to fibromyalgia

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Is chronic pain a variant of depressive disease? The case of primary fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Psychological factors associated with primary fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Basal and post-dexamethasone cortisol and prolactin concentrations in depressed and non-depressed patients with chronic pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Dehydroepiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: Preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Muscle performance, electromyography and fibre type composition in fibromyalgia and work-related myalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Brucellosis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Does the chronic fatigue syndrome involve the autonomic nervous system?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

The specificity of the water test as a diagnostic procedure in Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Role of synthesis of nucleic acids and protein in adaptation to the external environment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Spinal factors in the generation of fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Fibrositis and psychologic disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Ovine Corticotropin-Releasing Factor Stimulates Somatostatin Secretion from Cultured Brain Cells*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Morphologic aspects of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Adrenocortical activity and some clinical findings in acute and chronic fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Inhibition of the LH surge in cyclic rats by stress is not mediated by opioids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

The low dose ACTH test in chronic fatigue syndrome and in health

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

What is chronic brucellosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Depressed Mood and Other Psychiatric Manifestations of Cushingʼs Syndrome: Relationship to Hormone Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Depression in patients with neuromyasthenia (benign myalgic encephalomyelitis).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

The prevalence of sexual abuse in women with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Antiserum to Somatostatin Prevents Stress-Induced Inhibition of Growth Hormone Secretion in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Affective distress in fibromyalgia syndrome is associated with pain severity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

Glucocorticoids: potent inhibitors and stimulators of growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970180-0

7 January 2021

10.1016/S0889-857X(05)70180-0

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11084955